BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 16979183)

  • 1. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis.
    Kragh-Hansen U; Watanabe H; Nakajou K; Iwao Y; Otagiri M
    J Mol Biol; 2006 Oct; 363(3):702-12. PubMed ID: 16979183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin.
    Bhattacharya AA; Grüne T; Curry S
    J Mol Biol; 2000 Nov; 303(5):721-32. PubMed ID: 11061971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites.
    Curry S; Mandelkow H; Brick P; Franks N
    Nat Struct Biol; 1998 Sep; 5(9):827-35. PubMed ID: 9731778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro binding of fatty acids to genetic variants of human serum albumin.
    Kragh-Hansen U; Nielsen H; Pedersen AO
    Int J Clin Pharmacol Res; 1995; 15(2):33-43. PubMed ID: 8593972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal stabilization of human albumin by medium- and short-chain n-alkyl fatty acid anions.
    Shrake A; Frazier D; Schwarz FP
    Biopolymers; 2006 Mar; 81(4):235-48. PubMed ID: 16273515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
    Fujiwara S; Amisaki T
    Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
    Simard JR; Zunszain PA; Hamilton JA; Curry S
    J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of myristic acid on furosemide binding to bovine serum albumin. Comparison with furosemide-human serum albumin complex.
    Bojko B; Sułkowska A; Maciazek-Jurczyk M; Równicka J; Sułkowski WW
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Jun; 76(1):6-11. PubMed ID: 20308015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding.
    Kaneko K; Chuang VT; Minomo A; Yamasaki K; Bhagavan NV; Maruyama T; Otagiri M
    IUBMB Life; 2011 Apr; 63(4):277-85. PubMed ID: 21488149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalosporin binding sites to human serum albumin and the relation with the N-B transition of this protein.
    Nerli B; García F; Ballán C; Picó G
    Biochem Mol Biol Int; 1995 May; 36(1):177-84. PubMed ID: 7663413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids.
    Petitpas I; Grüne T; Bhattacharya AA; Curry S
    J Mol Biol; 2001 Dec; 314(5):955-60. PubMed ID: 11743713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tryptophan fluorescence lifetimes in a series of human serum albumin mutants with substitutions in subdomain 2A.
    Siemiarczuk A; Petersen CE; Ha CE; Yang J; Bhagavan NV
    Cell Biochem Biophys; 2004; 40(2):115-22. PubMed ID: 15054218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for drug binding to site II on human serum albumin.
    Wanwimolruk S; Birkett DJ; Brooks PM
    Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis and fatty acid-binding properties of two Croatian variants of human serum albumin.
    Kragh-Hansen U; Campagnoli M; Dodig S; Nielsen H; Benko B; Raos M; Cesati R; Sala A; Galliano M; Minchiotti L
    Clin Chim Acta; 2004 Nov; 349(1-2):105-12. PubMed ID: 15469862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The location of the high- and low-affinity bilirubin-binding sites on serum albumin: ligand-competition analysis investigated by circular dichroism.
    Goncharova I; Orlov S; Urbanová M
    Biophys Chem; 2013; 180-181():55-65. PubMed ID: 23838624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin.
    Hein KL; Kragh-Hansen U; Morth JP; Jeppesen MD; Otzen D; Møller JV; Nissen P
    J Struct Biol; 2010 Sep; 171(3):353-60. PubMed ID: 20347991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenesis studies of thyroxine binding to human serum albumin define an important structural characteristic of subdomain 2A.
    Petersen CE; Ha CE; Harohalli K; Park D; Bhagavan NV
    Biochemistry; 1997 Jun; 36(23):7012-7. PubMed ID: 9188698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin. Optical and NMR spectroscopy characterization.
    Fanali G; Fesce R; Agrati C; Ascenzi P; Fasano M
    FEBS J; 2005 Sep; 272(18):4672-83. PubMed ID: 16156788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a human serum albumin fragment (consisting of subdomains IA, IB, and IIA) and a study of its properties.
    Park DS; Petersen CE; Ha C; Harohalli K; Feix JB; Bhagavan NV
    IUBMB Life; 1999 Aug; 48(2):169-74. PubMed ID: 10794593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.